Performance of noninvasive prenatal screening in twin pregnancies: a retrospective study of 5469 twin pregnancies

References

• Prats P, Rodriguez I, Comas C, et al. Systematic review of screening for trisomy 21 in twin pregnancies in first trimester combining nuchal translucency and biochemical markers: a meta-analysis. Prenat Diagn. 2014;34(11):1077–1083.
   PubMed Web of Science ®Google Scholar
• Garchet-Beaudron A, Dreux S, Leporrier N, et al. Second-trimester Down syndrome maternal serum marker screening: a prospective study of 11040 twin pregnancies. Prenat Diagn. 2008;28(12):1105–1109.
   PubMed Web of Science ®Google Scholar
• Vink J, Fuchs K, D'Alton ME. Amniocentesis in twin pregnancies: a systematic review of the literature. Prenat Diagn. 2012;32(5):409–416.
   PubMed Web of Science ®Google Scholar
• Gjerris AC, Loft A, Pinborg A, et al. Prenatal testing among women pregnant after assisted reproductive techniques in Denmark 1995–2000: a national cohort study. Hum Reprod. 2008;23(7):1545–1552.
   PubMed Web of Science ®Google Scholar
• Porreco RP, Garite TJ, Maurel K, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol. 2014;211(6):711–712.
   Web of Science ®Google Scholar
• Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372(17):1589–1597.
   PubMed Web of Science ®Google Scholar
• Warsof SL, Larion S, Abuhamad AZ. Overview of the impact of noninvasive prenatal testing on diagnostic procedures. Prenat Diagn. 2015;35(10):972–979.
   PubMed Web of Science ®Google Scholar
• Rose NC, Kaimal AJ, Dugoff L, et al. Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226. Obstet Gynecol. 2020;136(4):e48–e69.
   PubMed Web of Science ®Google Scholar
• Palomaki GE, Chiu RWK, Pertile MD, et al. International Society for Prenatal Diagnosis Position Statement: cell free (cf)DNA screening for Down syndrome in multiple pregnancies. Prenat Diagn. 2020. doi:10.1002/pd.5832
   Google Scholar
• Sarno L, Revello R, Hanson E, et al. Prospective first trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy. Ultrasound Obstet Gynecol. 2016;47(6):705–711.
   PubMed Web of Science ®Google Scholar
• Fosler L, Winters P, Jones KW, et al. Aneuploidy screening by non-invasive prenatal testing in twin pregnancy. Ultrasound Obstet Gynecol. 2017;49(4):470–477.
   PubMed Web of Science ®Google Scholar
• Liao H, Liu SL, Wang H. Performance of non-invasive prenatal screening for fetal aneuploidy in twin pregnancies: a meta-analysis. Prenat Diagn. 2017;37(9):874–882.
   PubMed Web of Science ®Google Scholar
• Le Conte G, Letourneau A, Jani J, et al. Cell-free fetal DNA analysis in maternal plasma as screening test for trisomies 21, 18 and 13 in twin pregnancy. Ultrasound Obstet Gynecol. 2018;52(3):318–324.
   PubMed Web of Science ®Google Scholar
• Gil MM, Galeva S, Jani J, et al. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis. Ultrasound Obstet Gynecol. 2019;53(6):734–742.
   PubMed Web of Science ®Google Scholar
• Liang DS, Lv WG, Wang H, et al. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing. Prenat Diagn. 2013;33(5):409–415.
   PubMed Web of Science ®Google Scholar
• Mazloom AR, Dzakula Z, Wang H, et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn. 2013;33(6):591–597.
   PubMed Web of Science ®Google Scholar
• Chiu RWK, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ. 2011;342(342):c7401.
   PubMedGoogle Scholar
• Yu SC, Chan KC, Zheng YW, et al. Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. Proc Natl Acad Sci U S A. 2014;111(23):8583–8588.
   PubMed Web of Science ®Google Scholar
• Huang L, Jiang T, Liu CX. Fetal loss after amniocentesis: analysis of a single center’s 7,957 cases in China. Clin Exp Obstet Gynecol. 2015;42:184–187.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Chervenak FA, McCullough LB, et al. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol. 2005;193(2):322–326.
   PubMed Web of Science ®Google Scholar
• Evans ML, Goldberg JD, Dommergues M, et al. Efficacy of second-trimester selective termination for fetal abnormalities: international collaborative experience among the world's largest centers. Am J Obstet Gynecol. 1994;171(1):90–94.
   PubMed Web of Science ®Google Scholar
• Gregg AR, Skotko BG, Benkendorf JL, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18(10):1056–1065.
   PubMed Web of Science ®Google Scholar
• Deng CC, Zhu Q, Liu S, et al. Clinical application of noninvasive prenatal screening for sex chromosome aneuploidies in 50,301 pregnancies: initial experience in a Chinese hospital. Sci Rep. 2019;9(1):7767.
   PubMed Web of Science ®Google Scholar
• Benachi A, Letourneau A, Kleinfinger P, et al. Cell-free DNA analysis in maternal plasma in cases of fetal abnormalities detected on ultrasound examination. Obstet Gynecol. 2015;125(6):1330–1337.
   PubMed Web of Science ®Google Scholar
• Bellver J, Casanova C, Garrido N, et al. Additive effect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein A concentrations and the increased false-positive rates in first-trimester Down syndrome screening. Fertil Steril. 2013;100(5):1314–1320.
   PubMed Web of Science ®Google Scholar
• Bevilacqua E, Gil MM, Nicolaides KH, et al. Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies. Ultrasound Obstet Gynecol. 2015;45(1):61–66.
   PubMed Web of Science ®Google Scholar
• Galeva S, Gil MM, Konstantinidou L, et al. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure. Ultrasound Obstet Gynecol. 2019;53(6):804–809.
   PubMed Web of Science ®Google Scholar
• Haghiac M, Vora NL, Basu S, et al. Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obesity. 2012;20(11):2213–2219.
   PubMed Web of Science ®Google Scholar
• Qiao LW, Yu B, Liang YT, et al. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing. Am J Obstet Gynecol. 2019;221(4):345.e1–345.e11.
   PubMed Web of Science ®Google Scholar
• Wright D, Syngelaki A, Akolekar R, et al. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213(1):62.e1–62.e10.
   PubMed Web of Science ®Google Scholar
• Lambert-Messerlian G, Kloza EM, Iii JW, et al. Maternal plasma DNA testing for aneuploidy in pregnancies achieved by assisted reproductive technologies. Genet Med. 2014;16(5):419–422.
   PubMed Web of Science ®Google Scholar